Faron to report final MATINS melanoma survival data at ESMO 2026
Faron said it will report final melanoma survival data from the MATINS study at ESMO 2026.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results.
Faron said it will report final melanoma survival data from the MATINS study at ESMO 2026.